DARZALEX FASPRO®DARZALEX®
This site is intended for US healthcare professionals.
DARZALEX FASPRO®DARZALEX®
Get in Touch
DARZALEX FASPRO®DARZALEX®
Expert VideosNCCN® RecommendationsPractice SupportPatient SupportAdditional Studies
Get in Touch
FAQs
Patient Site
MM Portfolio
For Healthcare Providers
For Healthcare
Providers
Check IconNOW
APPROVED

DARZALEX FASPRO® + VRd is approved in transplant-ineligible patients with newly diagnosed multiple myelomaNDMM1

DARZALEX FASPRO® monotherapy is the first and only FDA-approved treatment in high-risk smoldering multiple myeloma1DARZALEX FASPRO® monotherapy is now approved in high-risk smoldering multiple myeloma1

MECHANISM OF
ACTION VIDEOS

MOA Video Library
VideoImage
DARZALEX FASPRO® MOA Video

View the DARZALEX FASPRO® MOA video
and be sure to recommend it to your patients. The video explains the science behind the active ingredients in DARZALEX FASPRO®.

VideoImage
DARZALEX® MOA Video

View the DARZALEX® MOA video. Share it with your patients to help explain how daratumumab, the active ingredient in DARZALEX®, works in the body.